Overview

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of a fixed-dose, single-capsule budesonide(400µg)-formoterol(12µg) combination, in comparison with budesonide alone, both delivered via a dry powder inhaler, in 181 patients with uncontrolled asthma.This was Randomized, double-blind, multicenter, phase III, parallel clinical trial.

Phase:

Phase 3

Details

Lead Sponsor:

Ache Laboratorios Farmaceuticos S.A.

Treatments:

Adrenergic beta-2 Receptor Agonists
Budesonide
Budesonide, Formoterol Fumarate Drug Combination
Formoterol Fumarate